BluePeak Autofluorescence

“BluePeak autofluorescence adds a functional indicator of retinal health by measuring the metabolic activity of the RPE,” said Karl Csaky MD, PhD, Retina Foundation of the Southwest. “Recent results from the Geographic Atrophy Progression (GAP) study clearly demonstrate the need to use autofluorescence to track the progression of geographic atrophy for dry AMD patients.

Looking for Small Changes with Precision Eye Tracking

Whether it is glaucoma, pre-op surgical assessment or adjusting anti-VEGF therapy, confidently detecting and assessing small changes may change your treatment decision. In diagnostic imaging, motion artifact is the number one problem limiting confident detection of small change.

Spectralis® solves this problem by using cSLO technology to track the eye and guide OCT to the selected location. TruTrack™ Eye Tracking comes from a long history of image alignment know-how, validated in longitudinal studies such as the Ocular Hypertension Treatment Study.

Not only are the scans guided on first examination, TruTrack™ automatic retinal recognition technology enables follow-up examinations to be scanned in the same exact location without relying on subjective operator judgment.

Finely Detailed Images with Heidelberg Noise Reduction™

In the new era of spectral-domain OCT, fast scanning speed is not enough. Just like Dolby® noise reduction eliminates static in sound recordings, Heidelberg Noise Reduction technology eliminates speckle (static) in images, revealing fine detail in the retinal layers.

Combining eye tracking with noise filtering technology enables the Spectralis® to produce stunning new images of all of the retinal layers. New anatomical structures are already being uncovered which may lead to a better understanding of disease and help guide therapeutic decisions.

Automatic Rescan Eliminates Subjective Operator Intervention

Tracking Laser Tomography is different than single beam “OCT only” systems. By combining the best of confocal scanning laser technology (cSLO) and spectral-domain OCT, the Spectralis® not only guides the images to the retina on the first scan, it can be used to guide the follow-up exam.

The system uses the doctor’s decision on scan location, automatically scanning in the same location on follow-up and does not rely on the operator’s subjective judgment.

Stopping Motion Artifact in Spectral-domain OCT

The real breakthrough in imaging has not been “high resolution” imaging, it is the ability to minimize or eliminate eye motion artifact, enabling highly detailed images of retinal pathology. Having the fastest scan speeds, combined with TruTrack™ dual beam scanning, enables Spectralis® to outrun most saccades which cause motion artifact in other 3-D OCT images.